Two independent Ludwig Cancer Research studies published in the current issue of the journal Cell show that immune cells known as neutrophils, whose abundance in the microenvironment of tumors has traditionally been associated with poor patient prognosis, can play an important role in the success of cancer immunotherapies.
ASCO 2023: Immunotherapy for brain cancer metastases shows
ESMO 2016: Ceritinib provides longer PFS than chemo in trial of
Surprise Finding Shows That Neutrophils Can Be Key Antitumor
Positive results from pivotal phase 3 trial evaluating nivolumab
Milestone of cancer research: Arresting cancers rather than
AIRE polymorphism, melanoma antigen-specific T cell immunity, and
ASCO GI: Less chemotherapy may have more benefit in rectal cancer
Tiago Biachi no LinkedIn: Two cancer research studies reveal
Study identifies how microbiome may affect pancreatic cancer
Positive opinion for orphan drug designation for avelumab in
